FDA, EMEA To Hold Joint Scientific Advice Meetings With Sponsors
This article was originally published in The Pink Sheet Daily
Executive Summary
One-year pilot program will launch in January to address specific development issues for breakthrough products. Meetings will provide an "opportunity to optimize product development" and are expected to help avoid unnecessary replication or divergence in agency methodologies, FDA and EMEA say.